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A B S T R A C T   
Canada legalized recreational cannabis use for adults on October 17, 2018 with decision-makers emphasising the 
need to reduce cannabis use among youth. We sought to characterise trends of youth cannabis use before and 
after cannabis legalization by relying on a quasi-experimental design evaluating cannabis use among high school 
students in Alberta, British Columbia, Ontario, and Québec who participated in the COMPASS prospective cohort 
study. Overall trends in use were examined using a large repeat cross-sectional sample (n = 102,685) at two time 
points before legalization (16/17 and 17/18 school years) and one after (18/19 school year). Further differential 
changes in use among students affected by legalization were examined using three sequential four-year longi-
tudinal cohorts (n = 5,400) of students as they progressed through high school. Youth cannabis use remains 
common with ever-use increasing from 30.5% in 2016/17 to 32.4% in 2018/19. In the repeat cross-sectional 
sample, the odds of ever use in the year following legalization were 1.05 times those of the preceding year 
(p = 0.0090). In the longitudinal sample, no significant differences in trends of cannabis use over time were 
found between cohorts for any of the three use frequency metrics. Therefore, it appears that cannabis legalization 
has not yet been followed by pronounced changes on youth cannabis use. High prevalence of youth cannabis use 
in this sample remains a concern. These data suggest that the Cannabis Act has not yet led to the reduction in 
youth cannabis use envisioned in its public health approach.   
1. Introduction 
Canada federally legalized recreational cannabis use for adults aged 
18 or over (Bill C-45, An Act respecting cannabis and to amend the 
Controlled Drugs and Substances Act, the Criminal Code and other Acts, 
“Cannabis Act”) on October 17, 2018 (Parliament of Canada, 2018). In 
laying the groundwork for this change, researchers and federal policy 
makers emphasised public health considerations, including the need to 
prevent harmful effects on cannabis use among youth (Spithoff et al., 
2015). The importance of youth protection was subsequently high-
lighted in both the Cannabis Act via the first two stated purposes of the 
Act [“(a) to protect the health of young persons by restricting their ac-
cess to cannabis; (b) to protect young persons and others from in-
ducements to use cannabis” (1, pg. 6)], and by the Task Force on 
Cannabis Legalization, which noted that Canadian youth are more likely 
to use cannabis than their international peers as well as Canadian adults 
(Task Force on Cannabis Legalization and Regulation, 2016; UNICEF 
Office of Research, 2013; Grant and Bélanger, 2017). The adverse effects 
of cannabis use on developing brains and the fact that adult substance 
use trajectories are most often rooted in adolescence were likewise 
identified as factors to consider during the legalization process (Task 
Force on Cannabis Legalization and Regulation, 2016; Patte et al., 2017; 
Coffey and Patton, 2016; Melchior et al., 2017; Maggs et al., 2015; 
Volkow et al., 2014; Degenhardt et al., 2010; Macleod et al., 2004; 
Kalant, 2016; Ammerman and Tau, 2016). 
Evidence on the effect of cannabis law liberalization on youth 
cannabis use has so far been mixed, and though many investigations 
have detected few harmful consequences others found that youth were 
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adversely affected (Wen et al., 2015; Stolzenberg et al., 2016; Stevens, 
2019; Goodman et al., 2020; Melchior et al., 2019; Castillo-Carniglia 
et al., 2020; Philbin et al., 2019; Ammerman et al., 2015; Shi et al., 
2015; Williams and Bretteville-Jensen, 2014; Hasin et al., 2015; Cerdá 
et al., 2018, 2017; Choo et al., 2014; Schinke et al., 2017). Analysis of 
Canadian policy effects is further complicated by the lack of a compar-
ison group. Uruguay is the only other country to have federally legalised 
recreational cannabis use, and though Portugal has broadly decrimin-
alised drug use and only a minority of US states have not somewhat 
liberalised access to medical or recreational cannabis (Arie, 2013; van 
het Loo et al., 2002; National, 2020; State medical, 2020), policy ap-
proaches in most of these contexts have tended to be market-driven 
rather than informed by principles of public health (Watson and Erick-
son, 2019). Interpretation of the evidence has also been hampered by the 
recency of policy change and scientific evaluations as well as differences 
in methodological approaches (Midgette and Reuter, 2020; Johnson and 
Guttmannova, 2019). 
In Canada, the 2018 National Cannabis Survey (NCS) found that a 
substantial proportion of youth and young adults (aged 15–24) intended 
to try cannabis or increase their use following legalization (Sandhu 
et al., 2019 Jun 14). There is also evidence that occasional cannabis use 
by youth rose after restrictions around medical cannabis access were 
loosened (Parker, 2000; Canada, 2016; Smith, 2015; Cox, 2018), prior to 
legalization (Zuckermann et al., 2019). Considering this extended 
timeline of possible cannabis policy changes, results from Canadian 
studies with insufficient pre-legalization time points may be biased. For 
instance, the NCS only commenced data collections in the first quarter of 
2018, several years after medical cannabis access restrictions were first 
loosened (Statistics Canada, 2018 Apr). And though the NCS and the 
annual Canadian Cannabis Survey contain the most comprehensive 
measures on cannabis use in Canada, both are limited in terms of rele-
vance to understanding youth cannabis use by the cross-sectional nature 
of the data collected and the exclusion of Canadians under 15 years of 
age (Canada and Survey, 2019; Statistics Canada, 2019). More longi-
tudinal and youth-focused data will be essential in evaluating the short- 
and long-term effects of cannabis legalization. 
COMPASS, a large prospective cohort study of secondary school 
students in Canada, has been collecting unique data on youth cannabis 
use since 2012 (Leatherdale et al., 2014). The study is therefore ideally 
placed to examine trends in cannabis use before and after legalization 
occurred. The objectives of the present work were to make use of the 
nationally unique data available in COMPASS to investigate the effects 
of cannabis legalization in Canada on cannabis use metrics among youth 
(ever use, current use, and frequency of use) using both repeat cross- 




The COMPASS Study (COMPASS) is a prospective cohort study 
(2012–2021) designed to collect hierarchical and longitudinal data from 
a convenience sample of secondary school students in a sample of 
provinces in Canada (Leatherdale et al., 2014 Dec 8). Using active- 
information, passive-consent parental permission protocols, eligible 
consenting students completed the COMPASS questionnaire (Cq) during 
class time. The Cq is an anonymous, self-administered questionnaire 
with items based on national guidelines or surveillance tools as previ-
ously described (Cerdá et al., 2017; Schinke et al., 2017). All COMPASS 
procedures received ethics approval from the University of Waterloo 
Research Ethics Board (ORE 30118), as well as all participating school 
board review panels. A full description of the COMPASS study is avail-
able online (www.compass.uwaterloo.ca) and in print (Leatherdale 
et al., 2014). 
The current study used a quasi-experimental design, relying on both 
repeat cross-sectional data to examine overall trends in use, and 
sequential cohort longitudinal data to examine the differential changes 
in use among students affected by legalization. The null hypothesis for 
natural experiment evaluation of an intervention is that the intervention 
had no effect. The repeat cross-sectional analysis relied on data from 
Time 1 in 2016–17 (T1; Year 5, baseline 2 years pre-legalization), Time 2 
in 2017–18 (T2; Year 6, baseline immediately pre-legalization), and 
Time 3 in 2018–19 (T3; Year 7, post-legalization). All Year 7 data col-
lections took place after October 17, 2018, post-implementation of Bill 
C-45. The longitudinal analysis relied on data from three cohorts staring 
in 2013–14 with Cohort 1 (C1; grade 9 in 2013–14, not impacted by 
legalization), followed by Cohort 2 (C2; grade 9 in 2014–15, graduating 
just before legalization) and Cohort 3 (C3; grade 9 in 2015–2016, 
impacted by legalization during grade 12 in 2018–19). Evaluating the 
impact of the Cannabis Act implementation is challenging due to the 
lack of a non-exposed control group (Leatherdale, 2019). Given avail-
able data, our quasi-experimental evaluation using a longitudinal 
cohort-control pre-post approach (Shadish et al., 2002) was the stron-
gest design and included repeat cross-sectional data pre-post legaliza-
tion to help triangulate the longitudinal results. 
2.2. Sample 
The repeat cross-sectional sample consisted of 76 schools in Alberta 
(n = 7), British Columbia (n = 3), Ontario (n = 55) and Québec (n = 11) 
that consistently participated in three years of COMPASS study pre-post 
legalization. Data from students in grades 9–12 in Alberta, British 
Columbia, and Ontario and students in Secondary 3–5 in Québec 
(equivalent to grades 9–11) at three time points (T1 n = 36,045; T2 n =
35,825; T3 n = 35,250) were used. Participation rate among eligible 
students was 77.5% in 2016–17, 81.8% in 2017–18, and 84.2% in 
2018–19. Longitudinal cohort student data from students in grade 9 in 
their baseline year (C1 n = 1,916; C2 n = 1,875; C3 n = 1,868) were 
collected in COMPASS years 2–7 (school years 2013/14 to 2018/19) at 
schools in Alberta (n = 3) and Ontario (n = 46). Longitudinal student 
data are obtained through an anonymous linking process using a self- 
generated identification code which allows matching of student re-
sponses over time described in detail in COMPASS technical reports 
(Battista et al., 2019; Qian et al., 2015). The cohorts included the subsets 
of students in grade 9 in their baseline year who were successfully linked 
across four consecutive years. 
2.3. Measures 
Students provided demographic information on grade (ON/AB/BC: 
9, 10, 11, 12; QC: Secondary 3, 4, 5), gender (female, male), ethnicity 
(Asian, Black, Hispanic, White, Other/Mixed) and weekly spending 
money (none, $1-$20, $21-$40, $41-$100, more than $100, don’t 
know), which is a proxy for socioeconomic status. Participants were 
asked “In the last 12 months, how often did you use marijuana or 
cannabis? (a joint, pot, weed, hash)”. Response options included “I have 
never used marijuana”, “I have used marijuana but not in the last 12 
months”, and frequency options ranging from “Less than once a month” 
to “Every day”. Cannabis ever-use was defined as any previous cannabis 
use and current use as use of at least “once a month” or more frequent. 
Among cases classified as ever-use, regular use was defined as use that 
occurred at least “once a week” or more frequently and occasional use 
was defined as use occurring “1 to 3 times a month” or less often. 
2.4. Statistical analysis 
For the repeat cross-sectional analysis, 4.1% of students with missing 
values for any measures were excluded from the analysis, resulting in a 
final sample of 34,416 students at T1, 34,470 students at T2, and 33,799 
students at T3. A summary of missing responses is provided in Supple-
mentary Table 2. Higher rates of missing cannabis use frequency data 
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were observed for males and minority ethnicities; however, given the 
low overall rate of missingness (<5%), any potential bias due to missing 
data is expected to be limited and imputation methods may only have 
negligible impacts on bias reduction (Schafer, 1999; Dong and Peng, 
2013; Jakobsen et al., 2017). Using the complete case sample, cannabis 
use frequency trends over time were examined by grade, gender, and 
province. Logistic regression was performed using generalized esti-
mating equations (GEE) with binomial distribution and logit link func-
tion to examine differences in population-average odds of cannabis use 
while accounting for school-level clustering. A working exchangeable 
log odds ratio correlation structure was used; however, GEE methods are 
robust to the misspecification of the covariance structure (Fitzmaurice 
et al., 2008). The odds of ever use (Model 1) and current use of cannabis 
among all students (Model 2), and the odds of regular use among those 
who indicated ever use of cannabis (Model 3) were examined by year, 
controlling for grade, gender, province, ethnicity, and spending money. 
T2 (2017–18) was chosen as the reference year as it served as a sepa-
ration between students unaffected by the (run-up to) legalization and 
students affected by it, allowing a direct comparison of pre- and post- 
legalization years. Additional models with year interactions for grade, 
gender, and province were tested to examine potential differential 
trends. No meaningful interactions were found (results not presented) 
and these were therefore excluded from the final models. 
In the longitudinal analysis, 4.6% of students with missing values for 
any measures were excluded from the analysis, resulting in a final 
sample of 1,825 students in Cohort 1 (C1), 1,786 students in Cohort 2 
(C2), and 1,789 students in Cohort 3 (C3). A summary of missing re-
sponses is provided in Supplementary Table 1. Consistent with previous 
findings (Qian et al., 2015), baseline cannabis use was less prevalent 
among students who were successfully linked than among those who 
were not. Using the complete case sample, chi-square tests were used to 
examine differences in baseline characteristics by cohort. Logistic 
regression was performed using GEE with binomial distribution and 
logit link function to examine differences in population-average odds of 
cannabis use while accounting for within-student correlation of re-
sponses. GEE (i.e. marginal) models were chosen over random- and 
fixed-effects approaches in alignment with the objective of examining 
overall population-averaged effects (Fitzmaurice et al., 2011; Gunase-
kara et al. Feb, 2014). The resulting coefficients of GEE models provide a 
population-level interpretation appropriate when examining between- 
student variables such as cohort differences (Fitzmaurice et al., 2011). 
A working exchangeable correlation structure was used (Fitzmaurice 
et al., 2011). The odds of ever use (Model 4) and current use of cannabis 
among all students (Model 5), as well as the odds of regular use among 
those who indicated ever use of cannabis (Model 6) were examined by 
cohort and grade, controlling for gender, province, ethnicity, and 
spending money. Analogously to the cross-sectional analyses, C2 
(baseline 2014–15) was chosen as the reference cohort to facilitate 
comparison of pre- and post-legalization grade 12 time points. Grade 
interactions with cohort were included to examine the differential in-
crease in odds of use by cohort. Further cohort and grade interactions 
with gender were tested but found to have no meaningful interactions 
(results not presented) and were therefore excluded from the final 
models. Statistical analyses were conducted in SAS 9.4. 
3. Results 
3.1. Sample characteristics 
The repeat cross-sectional sample of high school students examined 
Table 1 
Demographic and cannabis use characteristics of two samples of youth taking part in COMPASS who attended high school (grades 9–12) between 2013 and 14 and 
2018–19 (Canada).   
Repeat cross-sectional sample Longitudinal sample†














Chi-square test p- 
value  
n = 34 416 n = 34 470 n = 33 799  n = 1 825 n = 1 786 n = 1 789  
Gender         
Female 17 212 (50.0) 17 374 (50.4) 16 963 (50.2) 0.5886 989 (54.2) 973 (54.5) 943 (52.7) 0.5226 
Male 17 204 (50.0) 17 096 (49.6) 16 836 (49.8) 836 (45.8) 813 (45.5) 846 (47.3) 
Grade         
9 9 487 (27.6) 9 664 (28.0) 9 613 (28.4) 0.0450 1 825 1 786 1 789 – 
10 9 697 (28.2) 9 492 (27.5) 9 323 (27.6) “ “ “ 
11 8 726 (25.4) 8 943 (25.9) 8 552 (25.3) “ “ “ 
12 6 506 (18.9) 6 371 (18.5) 6 311 (18.7) “ “ “ 
Province         
Alberta 2 378 (6.9) 2 322 (6.7) 2 380 (7.0)  64 (3.5) 62 (3.5) 66 (3.7)  
British Columbia 1 795 (5.2) 2 187 (6.3) 2 145 (6.3) < 0.0001 – – – 0.9311 
Ontario 26 747 (77.7) 26 616 (77.2) 25 756 (76.2)  1761 (96.5) 1724 (96.5) 1723 (96.3)  
Québec 3 496 (10.2) 3 345 (9.7) 3 518 (10.4)  – – –  
Cannabis use§
Never 23 929 (69.5) 23 575 (68.4) 22 841 (67.6) < 0.0001 1 700 (93.2) 1 668 (93.4) 1 687 (94.3) 0.9261 
Not in past 12 
months 
1 677 (4.9) 1 584 (4.6) 1 464 (4.3) 35 (1.9) 29 (1.6) 30 (1.7) 
Less than once a 
month 
3 355 (9.7) 3 661 (10.6) 3 791 (11.2) 42 (2.3) 44 (2.5) 39 (2.2) 
1–3 times a month 2 235 (6.5) 2 378 (6.9) 2 410 (7.1) 24 (1.3) 22 (1.2) 16 (0.9) 
1–6 times a week 1 890 (5.5) 1 940 (5.6) 2 045 (6.1) 17 (0.9) 17 (1.0) 14 (0.8) 
Every day 1 330 (3.9) 1 332 (3.9) 1 248 (3.7) 7 (0.4) 6 (0.3) 3 (0.2) 
Derived categories of 
use         
Ever use 10 487 (30.5) 10 895 (31.6) 10 958 (32.4) -¶ 125 (6.8) 118 (6.6) 102 (5.7) -¶ 
Current use 5 455 (15.9) 5 650 (16.4) 5 703 (16.9) 48 (2.6) 45 (2.5) 33 (1.8) 
Occasional use‡ 7,267 (21.1) 7 623 (22.1) 7 665 (16.9) 101 (5.5) 95 (5.3) 85 (4.8) 
Regular use‡ 3 220 (9.4) 3 272 (9.5) 3 293 (9.7) 24 (1.3) 23 (1.3) 17 (1.0)  
† Characteristics at grade 9 reported with the listed school year indicating baseline. Complete case sample. Cohort 1/2/3 represent students who participated in 
COMPASS in grade 9 in 2013–14/2014–15/2015–16 respectively and continued to participate all three subsequent grades (10to12). § Counts reflect a pooled sample in 
the cross-sectional analysis and grade 9 baseline in the longitudinal analysis. ‡ Percentages indicate proportion of ever use. ¶ As derived categories of use are not 
mutually exclusive or exhaustive, no chi-square p-value is given. 
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was equally split in terms of gender with more than three quarters 
attending school in Ontario (Table 1). Most students did not report using 
cannabis, though the proportion of ever-use increased slightly over time 
from 30.5% at T1 (2016–17) to 32.4% at T3 (2018–19). Current use also 
increased between T1 and T3 (from 15.9% to 16.9%) among student 
who has ever used cannabis, the proportion using regularly remained 
flat (30.7% to 30.1%). Among the three cohorts in the longitudinally 
linked sample, female students were slightly overrepresented at baseline 
with between 52.7% and 54.5%. This sample was drawn only from 
Alberta and Ontario with more than 95% of students attending school in 
the latter province. Never-use of cannabis in grade 9 increased from 
93.6% in C1 to 94.3% in C3, though chi-square tests revealed no sig-
nificant differences in baseline sample characteristics between cohorts. 
3.2. Cross-sectional analyses 
Trends in cannabis use by gender, grade and province are presented 
in Fig. 1. Exploration of time trends in the repeat cross-sectional sample 
showed that cannabis ever use increased slightly over time. GEE 
modelling revealed that, after controlling for sociodemographic factors, 
the adjusted odds of cannabis ever use in the year following legalization 
of recreational cannabis use (T3: 2018–19) were 1.05 higher than those 
of the preceding year (T2: 2017–18; p = 0.0090) (Table 2; Model 1). 
There was no statistically significant difference in the odds of current use 
before and after legalization (AOR 1.04, p = 0.0703; Model 2) or the 
odds of regular use among those who had ever used (AOR 1.00, p =
0.9857; Model 3). Consistent with the trends seen in Fig. 1, male stu-
dents and students in higher grades had significantly higher odds of 
reporting cannabis ever and current use. Among students reporting ever 
use, male participants had higher odds of regular use, while no statis-
tically significant differences in odds of use were seen by grade. 
Compared to participants in Alberta, who reported the highest propor-
tion of all types of use investigated, students in Québec and British 
Columbia were significantly less likely to report regular cannabis use. 
However, there were no statistical differences between these provinces 
in the odds of ever or current use. Students in Ontario were no more 
likely than those in Alberta to report ever, current, or regular cannabis 
use. 
3.3. Longitudinal analyses 
Trends in overall cannabis use and cannabis use by gender are pre-
sented in Fig. 2. Grade 12 in cohort three represents the only post- 
legalization time point. Overall, differences in trends between cohorts 
appeared minor. Among male students in cohort 3, ever and current use 
appeared to increase more steeply between grades 11 and 12 than in the 
earlier two cohorts. In addition, among those who had indicated ever use 
of cannabis, regular use among male students in cohort 3 rose consis-
tently between grades 9 and 12. GEE modelling showed no significant 
differences over time/grade between cohorts in the odds of ever or 
current cannabis use, or of regular use among cases of ever use (Table 3). 
Here, male students had higher odds of current and regular use than 
female students but did not differ in terms of ever-use. A pronounced 
increase in the odds of ever and current use was seen as students pro-
gressed from grade 9 to grade 12 (Models 4 and 5), with a more modest 
but nonetheless significant increase in odds of regular use among cases 
of ever use in grades 11 and 12 (Model 6). AORs for the grade 12 
interaction terms for cohort 3 (representing the multiplicative increase 
in odds of use in the post-legalization period) were 1.20 (95% CI 0.91, 
1.58) for ever use, 1.44 (95%CI 0.91, 2.28) for current use, and 1.60 
(95% CI 0.29, 3.26) for regular use. All were non-significant at the α =
0.05 level. 
4. Discussion 
Considering a core objective of the Act is to prevent cannabis use and 
access among youth (Parliament of Canada, 2018), our longitudinal and 
cross-sectional results suggest that the Cannabis Act has not yet led to 
significant declines in youth cannabis use. The repeat cross-sectional 
analysis showed that cannabis ever use was significantly lower in the 
year before and significantly higher in the year after legalization 
compared to the year in which it took place, though this does not appear 
to have translated to a change in regular use. This result is in line with 
pre-legalization cannabis use trends observed by the authors in a similar 
sample, which showed an increase in occasional but not regular use 
starting several years prior to legalization (Zuckermann et al., 2019). As 
only a minority of adolescents who try cannabis proceed to use regularly 
(Schaub et al., 2010; Pérez et al., 2010; Legleye et al., 2016; Perkonigg 
et al., 1999), these results may similarly indicate increased experimen-
tation without progression into regular use. Further, the longitudinal 
analysis found no difference between the oldest and youngest cohorts, 
the latter of which included data from the only post-legalization time 
point. This suggests that levels of ever use post-legalization are in line 
with cohort-specific trends. However, the high prevalence of cannabis 
use in this sample remains a cause for concern and suggests that, to date, 
the Cannabis Act has not slowed or reversed concerning trends in youth 
cannabis use. 
Among the results presented are indications that the situation may 
continue to develop and therefore require future monitoring. Indeed, a 
previous investigation of cross-national trends found that the association 
between cannabis liberalisation and regular cannabis use among youth 
was only significant once five years had passed since the policy change 
(Shi et al., 2015). Here, use measures reported by male youth rose more 
steeply between grades 11 and 12 in cohort 3 than in the other cohorts. 
Male youth engage in more substance use than their female peers (Toci 
et al., 2014; Horwood et al., 2010; ter Bogt et al., 2014; Sussman and 
Dent, 2004; Zuckermann et al., 2020, 2019), so it is possible that this rise 
may be more pronounced, or appear earlier, in forthcoming cohorts, or 
that population subgroups at varying levels of existing risk are differ-
entially affected. Alternatively, female students may simply lag male 
students in this trend. A potential explanation may be found in evidence 
that female youth appear more affected by stigma associated with drug 
use (Haines-Saah et al., 2014) and by drug law liberalization (Shi et al., 
2015) and may therefore eventually either increase their cannabis use or 
decrease associated underreporting following the social normalization 
of cannabis use (Duff and Erickson, 2014; Brochu et al., 2011; Kolar 
et al., 2018; Duff et al., 2012; Parker et al., 2002; Parker, 2005). Female 
youth are also more likely to use alternative cannabis products, such as 
edibles, which are more prevalent in areas with liberal cannabis laws 
and whose production and sale has only recently been permitted in 
Canada (Goodman et al., 2020; Canada, 2016; Cuttler et al., 2016; Friese 
et al., 2016; Borodovsky et al., 2016, 2017; Knapp et al., 2019; Gov-
ernment of Canada, 2018). In this subpopulation, an increase in use of 
alternative forms of cannabis may bring with it more frequent use 
overall. 
Several provincial differences were also found. In the repeat cross- 
sectional model, students in Québec and British Columbia were signifi-
cantly less likely to report regular use than students in Alberta. In the 
longitudinal model, Alberta students also had significantly higher odds 
than Ontario students of reporting regular use. Some of these differences 
may have partially been due to sample composition, though others, such 
as the low rate of regular use in Québec, are supported by evidence 
gathered at the federal level (Rotermann, 2020; Statistics Canada, 
2020). All COMPASS Alberta schools are situated outside of large urban 
centres and there is some evidence that rural youth are at higher risk of 
substance use though this effect is not universal (Rose et al., 2018; Smith 
et al., 2008; Nargiso et al., 2015; Lambert et al., 2008). Alberta also has a 
very high density of cannabis retailers (2.0 per 100,000 population 
compared to 0.5 or lower for British Columbia, Ontario, and Québec) 
which may reflect higher levels of and/or contribute to normalisation 
(Myran et al., 2019; Statistics Canada, 2019; Pennay and Measham, 
2016; Sznitman and Taubman, 2016). Taken in combination with 
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Fig. 1. Cannabis use among three longitudinal cohorts of high school students who were attending grades 9–12 in Alberta (AB) and Ontario (ON) and taking part in 
COMPASS (Canada) starting at grade 9 in the 2013-14 (Cohort 1; C1), 2014-15 (Cohort 2; C2), and 2015/16 (Cohort 3; C3) school years. Students reported cannabis 
ever use (any previous use), current use (once a month or more often). Among students indicating ever use, frequency of use is differentiated by occasional use (up to 
three times a month) and regular use (once a week or more often). 
A.M.E. Zuckermann et al.                                                                                                                                                                                                                     
Preventive Medicine Reports 22 (2021) 101351
6
differing approaches to cannabis distribution and age restrictions 
(Government of Canada, 2020), as well as less tangible factors such as 
public health efforts, it is likely that provincial differences in youth 
cannabis use with persist and potentially become more pronounced over 
time. 
Continuing investigations will be required to track changes in youth 
cannabis use over time. In addition to the initial step of legalization, 
which itself followed liberalization of access to medical cannabis 
(Parker, 2000; Canada, 2016; Smith, 2015; Cox, 2018), further changes 
to regulations concerning topics such as alternative forms of cannabis or 
retail approaches are likely. The complexity of a developing regulatory 
landscape will be compounded by provincial differences in cannabis 
control, population demographics, and public health support. Future 
work must therefore not only characterise youth cannabis use overall, 
but also investigate how it is affected by individual, community, and 
provincial factors, including prevention and harm reduction programs, 
as recreational cannabis use becomes embedded in Canadian society. 
4.1. Strengths and limitations 
COMPASS benefits from several strengths, including prospective 
design, validated measures, large sample size, and extensive longitudi-
nal data from the pre-legalization period (Leatherdale et al., 2014). 
However, self-reports of cannabis use may be affected by recall and 
social desirability biases, leading to potential underreporting of 
cannabis use (Haines-Saah et al., 2014). In addition, youth who use 
cannabis regularly are more likely to skip class or drop out (Stiby et al., 
2015; Roebuck et al., 2004) and therefore miss data collection dates. 
This could result in further underestimations of cannabis use, particu-
larly in the longitudinal sample. To reduce these biases, COMPASS relies 
on an active-information, passive-consent approach which produces 
more representative samples and leads to robust estimations of risk 
behaviours among youth (Thompson-Haile et al., 2013; Hollmann and 
McNamara, 1999; Rojas et al., 2008; White et al., 2004). As COMPASS 
schools form a convenience sample, generalizability of results is limited. 
However, high rates of participation (between 77.5% and 84.2% in the 
cross-sectional sample) and the large sample size suggest results will 
nevertheless be applicable to a substantial proportion of Canadian 
youth. 
5. Conclusion 
Recreational cannabis legalization has not been followed by the 
slowing or reversing of concerning trends in youth cannabis use, sug-
gesting that, so far, the Cannabis Act has not yet led to the benefits for 
youth envisioned in adopting a public health approach to legalisation. 
Further monitoring will be essential in characterising its longer-term 
effects as well as to track impacts of additional regulatory changes. 
6. Data sharing 
COMPASS data are available to researchers upon successful 
completion of a data usage application. More information is available 
online at https://uwaterloo.ca/compass-system/information-researche 
rs. 
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Table 2 
GEE model results for repeat cross-sectional analysis of cannabis ever-use, current use, and regular use among cases of ever use among high school students taking part 
in COMPASS (Canada) at two time points (T1, T2) prior to and one (T3) following recreational cannabis legalization.  
Repeat cross-sectional analysis Model 1 Ever use vs never-use (ref) n =
102 685 
Model 2 Current use vs ever- and never-use (ref) n 
= 102 685 
Model 3 Regular use vs occasional use (ref) n 
= 32 340 
AOR (95% CI) p AOR (95% CI) p AOR (95% CI) p 
Time       
T1 (2016–17)† 0.94 (0.89, 0.99)  0.0107 0.96 (0.91, 1.01)  0.1163 1.04 (0.97, 1.12)  0.2759 
T2 (2017–18) (ref)‡
T3 (2018–19) 1.05 (1.01, 1.08)  0.0090 1.04 (1.00, 1.09)  0.0703 1.00 (0.93, 1.07)  0.9857 
Gender       
Female (ref)       
Male 1.13 (1.08, 1.19)  <0.0001 1.41 (1.33, 1.49)  <0.0001 1.77 (1.66, 1.90)  <0.0001 
Province       
Alberta (ref)       
British Columbia 0.95 (0.68, 1.33)  0.7539 0.87 (0.62, 1.20)  0.3895 0.93 (0.79, 1.11)  0.4331 
Ontario 0.90 (0.72, 1.13)  0.3758 0.95 (0.76, 1.18)  0.6341 1.07 (0.93, 1.23)  0.3518 
Québec 0.98 (0.73, 1.32)  0.9016 0.72 (0.55, 0.94)  0.0175 0.56 (0.46, 0.69)  <0.0001 
Grade       
9 (ref)       
10 1.96 (1.86, 2.08)  <0.0001 1.81 (1.69, 1.95)  <0.0001 1.04 (0.94, 1.14)  0.4557 
11 2.89 (2.71, 3.09)  <0.0001 2.30 (2.13, 2.50)  <0.0001 1.00 (0.90, 1.10)  0.9208 
12 3.98 (3.69, 4.30)  <0.0001 2.84 (2.60, 3.10)  <0.0001 1.01 (0.92, 1.12)  0.7864  
† indicates school year of data collection. Samples comprise all students without missing variables participating in COMPASS in a given school year. ‡ T2 was chosen 
as the reference year to facilitate comparison between students unexposed to the cannabis legalization process and those who were directly exposed. All models 
controlled for ethnicity, spending money and school-level clustering. 
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Fig. 2. Cannabis use among three longitudinal cohorts of high school students who were attending grades 9-12 in Alberta (AB) and Ontario (ON) and taking part in 
COMPASS (Canada) starting at grade 9 in the 2013-14 (Cohort 1; C1), 2014-15 (Cohort 2; C2), and 2015/16 (Cohort 3; C3) school years. Students reported cannabis 
ever use (any previous use), current use (once a month or more often). Among students indicating ever use, frequency of use is differentiated by occasional use (up to 
three times a month) and regular use (once a week or more often). 
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